Tyrosine Hydroxylase and Parkinson’s Disease

Haavik, Jan, Toska, Karen·1998·Molecular Neurobiology
DOI 10.1007/bf02741387

Cited by (264)

Items 201–264 of 264

  1. An oxygraphic method for determining kinetic properties and catalytic mechanism of aromatic amino acid hydroxylases
    Agnete Fossbakk, Jan Haavik · 2005 · Analytical Biochemistry
  2. Conformational study of the proline rich peptide from bovine neurohypophysis secretory granules
    Irada N. Alieva, Лала Ислам гызы Велиева, D. I. Aliev, N.M. Gojayev, S. D. Demukhamedova · 2003 · Journal of Molecular Structure
  3. Dopaminergic neuron differentiation of ventral mesencephalic progenitors regulated by developmental signals in vitro
    Yanxin Pei, Xiangping He, Zuoping Xie · 2003 · Neuroreport
  4. Environmental Substances Associated with Neurodegeneration: An Overview of Parkinson’s Disease and Related Genotoxic Endpoints
    Mohammad Shoeb, Breanna L. Alman, Harpriya Kaur, Moon Han, Fahim Atif, William Wu Kim, Siddhi Desai, Patricia Ruiz, Gregory M. Zarus · 2026 · Genes
  5. Serping1 associated with α-synuclein increase in colonic smooth muscles of MPTP-induced Parkinson’s disease mice
    Min Hyung Seo, Soo-Hwan Kim, Sujung Yeo · 2024 · Scientific Reports
  6. Therapeutic potential of Canna edulis RS3-resistant starch in alleviating neuroinflammation and apoptosis in a Parkinson's disease rat model
    Qian-Kun He, Xueyong Wang, Wei Hu, Jing Cai, Peng Chen, Ming-wei Liu, Yuan-Hua Wu · 2024 · Heliyon
  7. Coumarin-chalcone derivatives as dual NLRP1 and NLRP3 inflammasome inhibitors targeting oxidative stress and inflammation in neurotoxin-induced HMC3 and BE(2)-M17 cell models of Parkinson's disease
    Te‐Hsien Lin, Ya‐Jen Chiu, Chih‐Hsin Lin, Yi‐Ru Chen, Wenwei Lin, Yih‐Ru Wu, Kuo‐Hsuan Chang, Chiung‐Mei Chen, Guey‐Jen Lee‐Chen · 2024 · Frontiers in Aging Neuroscience
  8. Effect of D-amphetamine on dopaminergic neurons of substantia nigra and expression of tyrosine hydroxylase in striatum and pre-frontal cortex of D-amphetamine treated Wistar rats
    Sarun Koirala, Sandip A. Shah, Laxman Khanal · 2014 · Russian Open Medical Journal
  9. Double-stranded RNA-induced dopaminergic neuronal loss in the substantia nigra in the presence of Mac1 receptor
    Weixing Xu, Yinxi Wang, Huihui Quan, Dan Liu, Huifeng Zhang, Yuze Qi, Qingru Li, Jieying Liao, Hui‐Ming Gao, Jing Huang et al. · 2020 · Biochemical and Biophysical Research Communications
  10. Human neural stem cells promote mitochondrial genesis to alleviate neuronal damage in MPTP-induced cynomolgus monkey models
    Ying He, Ruicheng Li, Yuxi Yu, Chusheng Huang, Zhiran Xu, Tianbao Wang, Ming Chen, Hongri Huang, Zhongquan Qi · 2024 · Neurochemistry International
  11. Optimization of the Preparation Process of Glucuronomannan Oligosaccharides and Their Effects on the Gut Microbiota in MPTP-Induced PD Model Mice
    Baoxiang Wang, Lihua Geng, Jing Wang, Yuxi Wei, Changhui Yan, Ning Wu, Yang Yue, Quanbin Zhang · 2024 · Marine Drugs
  12. Identifying potential genes driving ferroptosis in the substantia nigra and dopaminergic neurons in Parkinson's disease
    Ardra Chakrabarti, Sonia Verma · 2025 · Molecular and Cellular Neuroscience
  13. EFFECTS OF INTRANASALLY ADMINISTERED DNSP-11 ON THE CENTRAL DOPAMINE SYSTEM OF NORMAL AND PARKINSONIAN FISCHER 344 RATS
    James H. Sonne · 2013 · UKnowledge (University of Kentucky)
  14. Antibodies and the Blood‐Brain Barrier
    Angela R. Jones, Eric V. Shusta · 2009 · Wiley eBooks
  15. Increased Activity of Tyrosine Hydroxylase Leads to Elevated Amphetamine Response and Markers of Oxidative Stress in Transgenic Mice
    Laura Marie Vecchio, Marie Kristel Bermejo, Amy R. Dunn, Marija Milenkovic, Nikhil M. Urs, Amy J. Ramsey, Gary Wright Miller, Ali Salahpour · 2017 · bioRxiv (Cold Spring Harbor Laboratory)
  16. Chrysin supplementation mitigated neurobehavioral changes in a animal model of Parkinson’s disease: Influence on TH+ neurons
    Marcelo Gomes de Gomes, André Tiago Rossito Goes, Lucian Del Fabbro, Leandro Cattelan Souza, Aliny Antunes Barbosa Lobo Ladd, Fernando Vagner Lobo Ladd, Silvana Peterini Boeira, Cristiano Ricardo Jessé · 2022 · Learning and Motivation
  17. New Step in Understanding the Pathogenetic Mechanism of Sudden Infant Death Syndrome: Involvement of the Pontine Reticular Gigantocellular Nucleus
    Anna Maria Lavezzi, Riffat Mehboob, Francesco Piscioli, Teresa Pusiol · 2024 · International Journal of Molecular Sciences
  18. Establishment of TH-EGFP human embryonic stem cell line for specific labeling of dopaminergic neurons
    Hoang‐Dai Tran, Charlotte R. Denman, Min‐Kyoung Shin, Dongju Jeon, Bernd Kühn, Junghyun Jo · 2024 · Stem Cell Research
  19. STUDIES OF THE EFFECTS OF DOPAMINE NEURON STIMULATING PEPTIDES IN RODENT MODELS OF NORMAL AND DYSFUNCTIONAL DOPAMINERGIC SYSTEMS
    Joshua L. Fuqua · 2010 · UKnowledge (University of Kentucky)
  20. Negligible Ability of Oxygen and Peroxide Ion Activation by Al(III) Ion Is Essential for Al(III)-Induced Neurodegeneration
    Yuzo Nishida · 2001 · Zeitschrift für Naturforschung C
  21. Therapeutic Botulinum Neurotoxin Ameliorates Motor Deficits and Anxiety, Accompanied by Dopaminergic Neuroprotection and Diminished Microglia Burden in the MPTP-Induced Mouse Model of Parkinson’s Disease
    Jerly Helan Mary Joseph, Mercy Priyadharshini Babu Deva Irakkam, Mahesh Kandasamy · 2025 · Brain Sciences
  22. Reflexiones sobre la Biosíntesis de la Morfina y el Parkinson Idiopático
    José Perea Sasiaín · 2007 · Revista de Salud Pública
  23. Aging with Parkinson’s Disease
    Joe R. Nocera, Keith McGregor · 2018 · Handbooks in health, work, and disability
  24. Odd correlation: Parkinson’s disease and melanoma. What is the possible link?
    Magdalena Maciejewska, Joanna Czuwara, Lidia Rudnicka · 2019 · Oncology in Clinical Practice
  25. No synergism between bis(propyl)-cognitin and rasagiline on protecting dopaminergic neurons in Parkinson's disease mice
    Yifan Han, Zai‐Jun Zhang, Chengyou Zheng, Bao-jian Guo, Wei Cai, Wei Cui, Shinghung Mak, Yuqiang Wang, Simon Ming‐Yuen Lee · 2016 · Neural Regeneration Research
  26. Reactive Oxygen Species and Reactive Nitrogen Species in Vitiligo
    Karin Uta Schallreuter · 2014 · Springer eBooks
  27. Engineering Regionally-Activated Drugs for Neuroscience
    Zhimin Huang, Andrei Mitrofan, Shirin Nouraein, Clark Horak, Joon Pyung Seo, Manwal Harb, Rongshu Jin, Jerzy O. Szablowski · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  28. Bone marrow cells differentiation to neurons in the rat brain using Serotonin and GABA:Their role on glutamate receptors, IP3, cAMP and cGMP functional regulation in unilateral Parkinsonism induced by 6-hydroxydopamine
    Mohan Sobhana Nandhu, C.S. Paulose · 2011 · Dyuthi Digital Repository (Cochin University of Science and Technology)
  29. Avaliação do efeito do éster fenetil do ácido cafeico (CAPE) em modelos experimentais da Doença de Parkinson
    Roberto de Barros Silva · 2014
  30. Genetic Modification of Human Embryonic Stem Cells
    Thomas P. Zwaka · 2007 · Human cell culture
  31. Molecular Cloning and Expression Analysis of TH Gene in the Ant Polyrhachis vicina (Hymenoptera: Formicidae)
    XI Geng-si · 2014 · Sociobiology
  32. Compensatory Mechanisms and T Cell Migration In Mouse Models of Dopaminergic Loss
    Kristi M. Anderson · 2015 · DigitalCommons@UNMC
  33. Charakterisierung 14–3-3 homologer Gene und deren Bedeutung für die Parkinson'sche Erkrankung
    S Mosbacher, Carsten Holzmann, K Hermann, Norbert Schwarz, Rejko Krüger, Tohru Ichimura, Olaf Rieß · 2005 · Aktuelle Neurologie
  34. Green tea polyphenols prevent Parkinson's disease: in vitro and in vivo studies
    Dan Chen · 2013
  35. Reflexiones sobre la Biosíntesis de la Morfina y el Parkinson Idiopático Reflections on the biosynthesis of morphine and idiopathic Parkinson's disease
    José Perea Sasiaín · 2007
  36. The effect of high frequency stimulation on intracellular Ca 2+ in sympathetic PC12 cells
    Yan Wo, Rong Xia, Feng Li, Wenlong Ding · 2009
  37. Genetics of cortico-cerebellar expansion in anthropoid primates: a comparative approach
    Peter W. Harrison, Stephen Hugh Montgomery · 2016 · bioRxiv (Cold Spring Harbor Laboratory)
  38. DOCTOR OF PHILOSOPHY IN BIOTECHNOLOGY
    Sandeep Kumar · 2013
  39. Homologous Recombination in Human Embryonic Stem Cells
    Thomas P. Zwaka, James Alexander Thomson · 2012 · Elsevier eBooks
  40. Tyrosine Hydroxylase
    Vernice R. Jackson-Lewis, Miquel Vila, Serge Przedborski · 2002 · Wiley Encyclopedia of Molecular Medicine
  41. Pesquisa de variantes genéticas em pacientes brasileiros com distonia idiopática
    Camila Alves · 2019
  42. Como os adaptógenos influenciam a performance cognitivo-mental: uma revisão integrativa
    Ângela Zago, Melissa Negro‐Dellacqua · 2022 · Research Society and Development
  43. Human genome or human microbiome genes: Which one is more important for human health and intellectual abilities?
    Elena L. Paley · 2023 · Elsevier eBooks
  44. REMOVED: Nanowired delivery of dl-3-n-butylphthalide with antibodies to alpha synuclein potentiated neuroprotection in Parkinson’s disease with emotional stress
    Lianyuan Feng, Aruna Sharma, Zhenguo Wang, Dafin Fior Muresanu, Z. Ryan Tian, José Vicente Lafuente, Anca Dana Buzoianu, Ala Nozari, Cong Li, Ziquiang Zhang et al. · 2023 · International review of neurobiology
  45. A Behavioural and Histological Approach to Dose Dependent Chronic Toxicity Screening of Cyclotide in Zebrafishes
    Muneeswari Muniyasamy, Rohini Durairaj, Boopathy Usharani, Arivukodi Deivasigamani, Shobana Chandrasekar · 2023 · Journal Of Advanced Zoology
  46. Possible Roles of Epigenetics in Stem Cell Therapy for Parkinson’s Disease
    P. Krubaa · 2024 · SBV Journal of Basic Clinical and Applied Health Science
  47. Effect Of Perinatal Perfluorinated Compounds (PFASs) Exposure On Behavior Of SD Rats
    Yuzi Sun, Dingyue Chai, Jiamin Lu, Yuhui Yao, Qianqian Cai, Min Peng, Lihui Wu · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  48. The Schizophrenia hypothesis: Tyrosine hydroxylase pathway
    Osman Özdemir · 2025 · Arşiv Kaynak Tarama Dergisi
  49. Parkinson's Disease: An Experimental Approach to Model the Visuo-Spatial Learning and Memory Deficits and an Analysis of Evidence Implicating α-Synuclein in Lewy Body Formation
    Caitlyn D. Ahlberg · 2014 · DigitalCommons (California Polytechnic State University)
  50. Molecular Profiling and Imaging of Peptides, Proteins and Drugs in Biological Tissue using Mass Spectrometry
    Anna Nilsson · 2008 · Uppsala University Publications (Uppsala University)
  51. Additional file 1 of Association of decreased triadin expression level with apoptosis of dopaminergic cells in Parkinson’s disease mouse model
    Min Hyung Seo, Lim, Sabina, Sujung Yeo · 2021 · Figshare
  52. Additional file 1 of ASC specks exacerbate α‑synuclein pathology via amplifying NLRP3 inflammasome activities
    Ran Zheng, Yan, Yiqun, Dai, Shaobing, Ruan, Yang, Chen, Ying, Chenjun Hu, Lin, Zhihao, Naijia Xue, Song, Zhe, Liu, Yi et al. · 2024 · Figshare
  53. Integrative Transcriptomic Analysis Identifies Novel Mitochondrial Gene Targets in Parkinson’s Disease
    Anusree Damodaran, Sanskriti Goswami, Neeraj Kumar, Sonia Verma · 2026 · Molecular Neurobiology
  54. Design, characterization and evaluation of a novel dosage form of rebamipide as transdermal patches in rodent model of Parkinson’s disease
    Akanksha Mishra, Sairam Krishnamurthy · 2026 · Prospects in Pharmaceutical Sciences
  55. Tribolium castaneum with longer duration of tonic immobility have more variations corresponding to the human Parkinson’s disease genomic region
    Keisuke Tanaka, Ken Sasaki, Shunsuke Yajima, Takahisa Miyatake · 2026 · Scientific Reports
  56. Neuromodulatory Effects of Substantia Nigra Pars Reticulata Deep Brain Stimulation (SNr-DBS) in the 6-Hydroxydopamine Rat Model of Parkinson’s Disease
    Eylem Telli Turgut, Hande Parlak, Pınar Eser Ocak, Yasin Temel, Ali Jahanshahi, Levent Sarıkçıoğlu, Gamze Tanrιöver, Tanju Uçar, Ersoy Kocabıçak, Aysel Agar · 2026 · Medicina
  57. Neuroprotective effects of serum- and glucocorticoid-regulated kinase 1 protein in a Parkinson's disease model
    Min Hyung Seo, Sun-Ho Kim, Soo-Hwan Kim, Sujung Yeo · 2026 · Neuropharmacology
  58. Integrative Nutrigenomic Systems Biology Analysis of Traditional Chinese Medicine Interventions in Parkinson’s Disease: Nutrient-Gene-Disease Network Perspectives
    Elham Amjad, Babak Sokouti · 2026 · OBM Genetics
  59. Neuroprotective effects of chitosan nanoparticle-loaded orientin in a 6-OHDA-induced Parkinson's disease experimental model in rats
    Volkan Gelen, Cemil Bayram, Adem Kara, Deniz Tekiner, Ali Yeşildağ · 2026 · Neuropharmacology
  60. PLXDC2 siRNA‐Mediated Intervention Attenuates Microglial Senescence Through cGAS‐STING Signaling
    Heyue Lu, Zitian Zheng, Feiran Wang, Huanhuan Luo, Fei Ju, Yucheng Zhu, Zheng Zhou, Jie Sun, Zhenghui Qiu, Xiang Luo et al. · 2026 · Advanced Science
  61. Transcranial magneto-acoustic stimulation modulates M1-PPN spike-LFP coupling and improves motor dysfunction in parkinsonian rats
    Shuai Zhang, Yi Wang, Yihao Xu, Xiaochao Lu, Shaocong Zhai, Ke Yue, Xiangyu Zhang, Penglei Liu, Guizhi Xu · 2026 · Experimental Neurology
  62. BindingDB Entry 50015448: Tetrahydrobiopterin binding to aromatic amino acid hydroxylases. Ligand recognition and specificity.
    BindingDB · 2009 · UC San Diego
  63. BindingDB Entry 50015795: In vitro and in vivo neuroprotective effect of novel mPGES-1 inhibitor in animal model of Parkinson's disease.
    BindingDB · 2023 · UC San Diego
  64. Tyrosine hydroxylase and HSPB8 interact with the prion protein
    Mattia Vicario · 2014 · Padua@research (University of Padova)